trending Market Intelligence /marketintelligence/en/news-insights/trending/ABONQmuKLgZSxqYeG1phAg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Zynerba Pharmaceuticals prices $50.4M common stock offering


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

Zynerba Pharmaceuticals prices $50.4M common stock offering

Zynerba Pharmaceuticals Inc. priced an underwritten offering of shares at $18 apiece.

The company will issue 2.8 million common shares to raise $50.4 million for the continued development of its cannabinoid-based treatments.

Underwriters can purchase up to an additional 420,000 of the shares offered. The issue is expected to close by Jan. 24.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.

Cantor Fitzgerald & Co. is acting as lead manager, and Oppenheimer & Co. and Roth Capital Partners are acting as co-managers for the offering.